bromfenac has been researched along with fluorometholone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Fujishima, H; Fukagawa, K; Fukushima, A; Miyazaki, D; Nakagawa, Y; Okamoto, S; Takano, Y; Tanaka, M; Uchio, E; Yamada, J | 1 |
Chen, PQ; Jin, CF; Shentu, XC; Wang, QW; Weng, Y; Wu, W; Xie, X; Xu, W; Yao, K; Yu, YH; Zhang, L; Zhu, YN | 1 |
Guo, N; Liu, J; Wang, MM; Xu, Y; Zhang, FJ; Zhang, QL; Zhao, X; Zheng, Y | 1 |
Chen, S; Jiang, Y; Li, Y; Yu, C | 1 |
Kim, YH; Lee, JS; Park, YM | 1 |
Goto, R; Isaka, T; Kawasaki, N; Kobayakawa, S; Matsunaga, T; Nagai, N; Ogata, F; Otake, H | 1 |
Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW | 1 |
1 review(s) available for bromfenac and fluorometholone
Article | Year |
---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract Extraction; Dexamethasone; Diclofenac; Fluorometholone; Humans; Macular Edema; Treatment Outcome | 2023 |
4 trial(s) available for bromfenac and fluorometholone
Article | Year |
---|---|
Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Benzophenones; Bromobenzenes; Conjunctivitis, Allergic; Cromolyn Sodium; Drug Therapy, Combination; Female; Fluorometholone; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Satisfaction; Suspensions | 2009 |
Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Fluorometholone; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Treatment Outcome; Uveitis | 2013 |
[The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis].
Topics: Adolescent; Adult; Benzophenones; Bromobenzenes; Female; Fluorometholone; Humans; Intraocular Pressure; Keratomileusis, Laser In Situ; Male; Myopia; Ophthalmic Solutions; Postoperative Period; Treatment Outcome; Young Adult | 2013 |
[Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
Topics: Benzophenones; Bromobenzenes; Corneal Topography; Dexamethasone; Drug Administration Schedule; Dry Eye Syndromes; Fluorometholone; Glucocorticoids; Humans; Intraocular Pressure; Keratectomy, Subepithelial, Laser-Assisted; Ophthalmic Solutions; Postoperative Period; Prospective Studies; Statistics, Nonparametric; Surgical Flaps; Tonometry, Ocular; Visual Acuity | 2015 |
2 other study(ies) available for bromfenac and fluorometholone
Article | Year |
---|---|
The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Benzopyrans; Bromobenzenes; Cell Movement; Cells, Cultured; Diclofenac; Epithelial Cells; Epithelium, Corneal; Fluorometholone; Humans; L-Lactate Dehydrogenase; Microscopy, Electron, Transmission; Ophthalmic Solutions; Propionates | 2015 |
Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration.
Topics: Animals; Benzophenones; Bromobenzenes; Cornea; Fluorometholone; Levofloxacin; Nanoparticles; Ophthalmic Solutions; Rabbits | 2021 |